Background: The Epithelial-Mesenchymal Transition (EMT) endows epithelial-looking cells with enhanced migratory ability during embryonic development and tissue repair. EMT can also be co-opted by cancer cells to acquire metastatic potential and drug-resistance. Recent research has argued that epithelial (E) cells can undergo either a partial EMT to attain a hybrid epithelial/mesenchymal (E/M) phenotype that typically displays collective migration, or a complete EMT to adopt a mesenchymal (M) phenotype that shows individual migration. The core EMT regulatory network -miR-34/SNAIL/miR-200/ZEB1 -has been identified by various studies, but how this network regulates the transitions among the E, E/M, and M phenotypes remains controversial. Two major mathematical models -ternary chimera switch (TCS) and cascading bistable switches (CBS) -that both focus on the miR-34/SNAIL/miR-200/ZEB1 network, have been proposed to elucidate the EMT dynamics, but a detailed analysis of how well either or both of these two models can capture recent experimental observations about EMT dynamics remains to be done.
Emerging evidence shows that in addition to epithelial (E) and mesenchymal (M) phenotypes, cells can acquire a hybrid epithelial/mesenchymal (E/M) phenotype (also referred to as 'partial EMT') that has combined traits of epithelial (cell-cell adhesion) and mesenchymal (invasion) phenotypes (6) (7) (8) (9) (10) (11) . Consequently, cells in the hybrid E/M phenotype can migrate collectively as a cluster (12) . These clusters, which originate from the primary tumor front, can display up to 50 times higher tumor-formation potential as compared to individually migratory mesenchymal cells (13) . In addition, the hybrid E/M phenotype has been suggested to be more correlated with stem-like properties (14, 15) and chemoresistance (16) as compared to epithelial and mesenchymal phenotypes. Thus characterizing the hybrid E/M phenotype can contribute to a full understanding of the role of EMT in metastasis and chemoresistance.
The signaling network orchestrating EMT is complex. For example, EMT can be triggered by many signaling pathways such as TGF-β, Notch and Wnt (17) , and different mechanical factors such as extracellular matrix density (18) and mechanical stress (19) . On the other hand, EMT can be repressed by tumor suppressors such as p53 (20) , transcription factors such as GRHL2 (21) and OVOL (22) , and microRNA families such as miR-200 and miR-34 (23) . Despite the complexity of the signaling network, there appears to exist a 'hub' that functions as the master regulator of EMT. This 'hub' consists of two interconnected mutually inhibitory feedback loops between microRNAs and transcription factors -one between the miR-34 family and SNAIL1/2, and the other between the miR-200 family and ZEB1/2 (24) (25) (26) . High levels of miR-200 and miR-34 are associated with an epithelial phenotype, and high levels of ZEB1/2 and SNAIL are associated with a mesenchymal phenotype (27) (28) (29) (30) .
Recently, two different mathematical models -the ternary chimera switch (TCS) (31) and the cascading bistable switches (CBS) (32) -have been proposed to elucidate phenotypic transitions during EMT (Figure 1A, B , see SI Section 1&2 for the details of model formulation). Both models focus on the aforementioned EMT regulatory circuits -miR-34/SNAIL and miR-200/ZEB (which will be referred to as miR-200/ZEB1 hereafter since the experimental results discussed later focus on ZEB1), and can explain the two-step transitions during EMT -E→E/M→M (Figure 1C, D) (31, 32) . Despite these similarities, however, the TCS and CBS models differ on an important aspect -the role of ZEB1 during EMT. The TCS model proposes that ZEB1 levels are trimodally distributed among E, E/M and M phenotypes, and intermediate levels of ZEB1 are required to maintain the hybrid E/M phenotype (31) . In other words, an upregulation of ZEB1 levels is required to both initiate partial EMT (E→E/M) and complete EMT (E/M→M) ( Figure 1E) . In contrast, the CBS model proposes that ZEB1 levels are bimodally distributed, such that the levels of ZEB1 in E and hybrid E/M phenotypes are relatively low and not significantly different, while that in M phenotype are relatively high (32) ( Figure 1F ). These differences in the proposed role of ZEB1 exist between TCS and CBS models because of the different characterizations of the EMT regulatory circuits by each model.
The TCS model proposes the miR-200/ZEB1 circuit to be the three-way decision-making switch of EMT and the miR-34/SNAIL to be a monostable noise-buffering integrator (31) . In contrast, the CBS model proposes that both the miR-34/SNAIL circuit and the miR-200/ZEB1 circuit are bistable switches, with miR-34/SNAIL responsible for the switch from E to E/M and miR-200/ZEB1 responsible for the switch from E/M to M (32) .
Despite modeling the same circuit, a key reason why these two models have different predictions is that the TCS model, but not the CBS model, includes the self-activation of ZEB1. It is in fact well-known that including self-activation in toggle switch systems can lead to tristability (33) (34) (35) . In this study, we first confirm the importance of the ZEB1 self-activation based on recently published work on the self-enforcing CD44s/ZEB1 feedback loop. The trimodal distribution of ZEB1 from the TCS modeling analysis is further supported by gene expression data from NCI-60 cell lines and the immunofluorescence (IF) results of the hybrid E/M non-small cell lung cancer (NSCLC) cell line -H1975.
Next, we show that both the TCS model and the CBS model can recapitulate currently published experimental results such as (a) EMT is a two-step transition -E to hybrid E/M to M, (b) a lower TGF-β concentration is required for the activation of SNAIL compared to that for ZEB1, (c) the transition from E to E/M is reversible while the transition from E/M to M is largely irreversible in MCF10A cells. Hence, much of the existing data does not distinguish between these two possibilities.
Hence, we present novel experimental data that is capable of discriminating between the two models. We show that overexpression of SNAIL in HMLE cells cannot induce EMT without the expression of ZEB1 (and FOXC2, which is another important mediator of EMT and is known to regulate ZEB1 (36) ). This observation suggests that the miR-34/SNAIL circuit may not be responsible for the switch from E to E/M phenotypes and is therefore more congruent with predictions from the TCS model.
Results
The CD44s/ZEB1 feedback loop enables the miR-200/ZEB1 circuit to function as a threeway switch.
The TCS model incorporates a direct ZEB1 self-activation link based on the contribution of ZEB1 in stabilizing the SMAD complexes; this link can reinforce ZEB1 levels that are raised via the TGF-β pathway (25) . Here, we include in the model recently published evidence regarding a self-reinforcing feedback loop of ZEB1 via ESRP1 and CD44s (37) (Figure 2A) , and show that this feedback loop indeed enables the tristability of the miR-200/ZEB1 circuit (see SI Section 3 for the model formulation of the CD44s/ZEB1 feedback loop and Table S1 for relevant parameters).
CD44, a crucial stem cell marker, has two major isoforms -CD44s (the CD44 standard isoform) and CD44v (CD44 variant isoform) (38) . Whereas the total amount of CD44 is maintained largely unchanged during EMT, the isoform switch from CD44v to CD44s is essential for the progression of EMT (39, 40) , and CD44s can upregulate ZEB1 (37) . This isoform switch is regulated by a splicing factor -epithelial splicing regulatory protein 1 (ESRP1) -which promotes the splicing of CD44v and inhibits that of CD44s (39) . The transcription of ESRP1 can be directly inhibited by ZEB1, and therefore ZEB1 can upregulate itself by promoting the production of CD44s (37, 39) .
To analyze the effect of the CD44s/ZEB1 feedback loop on the behavior of the miR-200/ZEB1 circuit, we calculated a bifurcation diagram (Figure 2A) to illustrate the existence of and transitions among the different stable states. The CD44s/ZEB1 feedback loop enables the miR-200/ZEB1 circuit to acquire three stable states (phenotypes) -(low ZEB1, high ESRP1)
corresponding to the E phenotype, (medium ZEB1, medium ESRP1) corresponding to the hybrid E/M phenotype and (high ZEB1, low ESRP1) corresponding to the M phenotype. The hybrid E/M phenotype is not seen upon removal of the CD44s/ZEB1 feedback loop (Figure S1) , demonstrating that self-activation in a toggle switch is critical for attaining more than two stable states (33) (34) (35) . To understand the diverse EMT-inducing results (e.g., by hypoxia, which can upregulate both SNAIL and ZEB1 or by TGF-, which mainly upregulates SNAIL), we feedback loop is quite robust to parameter perturbation (SI Section 4, Figure S2 ).
Next, to investigate the gene expression levels of ZEB1 across E, hybrid E/M and M cells, we
analyze the NCI-60 panel of cell lines that have been classified into E, E/M, and M phenotypes on a population level based on ensemble CDH1/VIM ratio (29) . CDH1 encodes the epithelial marker E-cadherin, loss of which is a hallmark of EMT. VIM encodes vimentin, which is a commonly used marker for the mesenchymal phenotype. Both ZEB1 and ESRP1 show three different expression levels across the E, E/M and M cell lines, and the difference among these levels is statistically significant (Figure 2C) . These results are consistent with the prediction from the TCS model, which proposes that ZEB1 (Figure 2A, B ) and ESRP1 levels (Figure S3) in the hybrid E/M phenotype are different from that of the E phenotype. Further, across the entire NCI-60 panel, ESRP1 expression negatively correlates with ZEB1 and VIM, and positively correlates with CDH1 (41) (42) (43) . These observations, together with the reported strong negative correlation between the expression of ZEB1 and ESRP1 in the lung, breast and pancreatic cancer patient samples (37) , suggest that the ZEB1-ESRP1 axis is active across multiple cancer types ( Figure 2C) .
In addition to the expression analysis of ZEB1 from the NCI-60 cell line panel, we further conducted experiments in three NSCLC cell lines -H820, H1975 and H1299 -that have been characterized as epithelial, hybrid E/M and mesenchymal respectively (44) . Notably, the hybrid E/M H1975 cells stain for both E-cadherin and vimentin at a single-cell level and display collective migration (44, 45) . The immunofluorescence staining of the H1975 cells clearly shows the expression of ZEB1 in the nucleus concomitantly with E-cadherin on the membrane, which demonstrates that ZEB1 is present in the hybrid E/M phenotype as compared to the lack of ZEB1 in the epithelial H820 cells (Figure 2D, Figure S4 Figure   S5 ). Notably, the difference of SNAIL levels (3 fold) is much smaller compared with the difference of ZEB1 (20 fold) between epithelial cells -H820 and H1437 and hybrid E/M cells -H1975 (Figure 2E, F ), suggesting ZEB1 levels may correspond strongly with maintaining these phenotypes, at least in these cell lines. Interestingly, the levels of SNAIL in mesenchymal cells -H1299 and H2030 were lower than those in epithelial cells -H820 and H1437 (Figure 2E, F) , further arguing for a more critical role of ZEB1 in maintaining a mesenchymal phenotype, potentially via multiple feedback loops (37, 46) .
These results indicate that ZEB1 self-activation (direct or indirect) should be considered an integral part of the core EMT circuit, thereby implying that TCS model captures the biological mechanisms more precisely than the CBS one. The parameter region of the bifurcation and phase diagram (Figure 2A, B) here is quite consistent with that for the miR-200/ZEB1 circuit with direct ZEB1 self-activation (see Fig. 4 in (31) for comparison). For simplicity, the CD44s/ZEB1 feedback loop is represented by a direct ZEB1 self-activation in the following analysis.
Next, we focus on published experimental data that has been claimed to support the CBS model over the TCS model. These experimental results are -(a) during TGF-β treatment of MCF10A cells, the concentration of exogenous TGF-β required to increase the SNAIL abundance is lower than that needed for a comparable increase in ZEB1 abundance (32) , and (b) MCF10A cells that attain a hybrid E/M phenotype revert to being epithelial upon removal of exogenous TGF-β, but cells that attain a mesenchymal phenotype fail to do so (32) . In the following two sections, we show that both the CBS and the TCS models can recapitulate these two experimental observations.
Different responses of SNAIL and ZEB1 to the EMT-inducing signal, exogenous TGF-β
To test whether the TCS model can recapitulate the different TGF-β-dose responses of SNAIL and ZEB1, we apply an EMT-inducing signal & on SNAIL to mimic the induction of exogenous TGF-β, and analyze the steady-state responses of SNAIL and ZEB1 to different levels of & . To investigate how differently SNAIL and ZEB1 respond to TGF-β induction at a single-cell level compared with that at a cell population level, we design two different kinds of stochastic simulations. First, at a single-cell level, in absence of a detailed understanding of the gene expression noise in regulating EMT, we consider the effects of white noise. Secondly, to investigate population-averaged results, we include cell-cell variability, which is represented by randomly assigned parameters to each cell. (Figure S6 ).
Next, we compare the responses of ZEB1 on the single-cell and population-averaged levels; we find that ZEB1 mRNA levels display a more significant trimodal distribution in the single-cell simulation compared with that from the population-averaged result (Figure 3C) . The cell-to-cell variability, as reflected by parameter randomization, tends to smoothen the distributions of ZEB1 mRNA in the E and the hybrid E/M phenotypes, potentially because the difference of ZEB1 mRNA levels between E and E/M is smaller as compared to that between E/M and M, as reflected by the simulations of single cells undergoing EMT (Figure 3A) . The difference of ZEB1 mRNA levels in E, E/M and M phenotypes shown here should not be compared with the gene expression data from NCI-60 (Figure 2C) , which is not time-course data for individual cells undergoing EMT. Since the existing experimental data on population measurements only yield average values, this may help explain why ZEB1 mRNA appears to be bimodally distributed (32) . Consequently, the averaged ZEB1 levels may not be able to argue strongly in favor of one mathematical model over the other. When there is no feedback from ZEB1 to miR-34, cells are mainly bimodally distributed in either the E or the E/M phenotype (left panel in Figure 4B ). An intermediate strength of the inhibition of miR-34 by ZEB1 enables all three phenotypes to be attained (middle panel in Figure 4B ). When the strength of the inhibition of miR-34 by ZEB1 is further increased, the M phenotype becomes the dominant one, thus cells in this case can maintain the mesenchymal phenotype without reverting (right panel in Figure 4B ). Therefore, a strong inhibitory feedback from ZEB1 to miR-34 stabilizes the mesenchymal phenotype and contributes to the irreversible transition from the hybrid E/M to the M phenotype.
The inhibition of miR-34 by ZEB1 as well as autocrine TGF-β signaling stabilizes the mesenchymal phenotype
Another possible mechanism accounting for the 'irreversibility' of the mesenchymal phenotype can be the autocrine TGF-β/miR-200 loop, as suggested by the CBS model. Here, we evaluate the effect of the TGF-β/miR-200 loop based on the TCS framework ( Figure 5A) and show that removal of exogenous TGF-β cannot induce MET but instead the circuit is able to maintain the mesenchymal phenotype (Phase {M} in Figure 5B ) as long as the innate production rate of endogenous TGF-β is high. This bifurcation diagrams (Figure 5C, D) indicate that the 'irreversibility' of mesenchymal phenotype to switch back to a hybrid E/M phenotype depends directly on the production rate of endogenous TGF-β.
In summary, both the TCS and the CBS models can explain currently published experimental results regarding EMT -(a) EMT is a two-step process, from E to E/M to M. (b) The concentration of exogenous TGF-β required for the activation of SNAIL is lower than that for ZEB1, (c) The mesenchymal phenotype can be maintained without reverting when exogenous TGF-β is removed due to certain levels of endogenous TGF-β. In addition, we show that the inhibition of miR-34 by ZEB1 can be responsible for the irreversibility of a complete EMT.
These EMT mathematical models are helpful to the extent that they can continue to explain and predict the regulatory effects of newly identified EMT players. To this end, we focus on adding recently identified EMT regulator -FOXC2, which plays a crucial role in EMT progression, to both the TCS and the CBS frameworks and test whether these two models can elucidate the function of FOXC2 in regulating EMT.
Overexpression of SNAIL is insufficient to initiate EMT in absence of ZEB1 and FOXC2
The transcription factor FOXC2 serves as a key mediator in regulating EMT and linking EMT with stem-like properties and with metastatic competence (36, (49) (50) (51) . FOXC2 expression can be upregulated by multiple EMT-inducing signals, such as TGF-β1, Snail Goosecoid and Twist. It has been shown that FOXC2 expression is required to maintain the mesenchymal phenotype, the invasive properties and the stem cell-enrichment of HMLE cells following EMT induction (36, 49) .
FOXC2 regulates EMT through its interactions with core EMT components -SNAIL and ZEB1.
Overexpression of SNAIL significantly upregulates the expression of FOXC2 while overexpression of FOXC2 does not affect SNAIL levels (49, 52) (Figure S8) . This suggests that SNAIL functions as an upstream regulator of FOXC2. In addition, FOXC2 directly upregulates the expression of ZEB1 by binding to its promoter region (51) . Here, we have expanded both the TCS and CBS models to include transcriptional regulation by FOXC2 (Figure 6A, Figure S9A , see SI Section 5&6 for model formulation and Table S2&3 for parameters). Is it possible that FOXC2 acts together with SNAIL and together can induce (partial) EMT even without ZEB1? This would argue against TCS and would instead be consistent with a modified version of CBS. We do not think this is supported by existing data. Observations in LNCaP and DU145 cells show that ZEB1 mediates the effect of FOXC2 on tumor-initiating potential and drug resistance (50) , traits that are often correlated with EMT (14, (53) (54) (55) (56) . Decreased expression of ZEB1 in PANC-1 cells, which express both epithelial and mesenchymal markers (57) and are thus likely to be hybrid E/M cells, results in a complete MET despite upregulation of SLUG and SNAIL in TGF-β treated cells (58) . Moreover, knockdown of ZEB1, but not necessarily of SNAIL and SLUG, had pronounced effects in cells losing their EMT-like properties (59) .
Therefore, we believe that the most consistent interpretation of the data is that SNAIL (even with Here, we discuss the similarities and differences between these two models and present a new set of experiments that appear to align better with the TCS model. First, we show that the CD44s/ZEB1 feedback loop can underlie the self-activation of ZEB1. These results, coupled with the significantly different levels of ZEB1 and ESRP1 across E, E/M and M phenotypes in the NCI-60 cell line, and the single-cell co-expression of ZEB1 and E-cadherin in H1975 hybrid E/M cells, reinforce the role of ZEB1 in partial EMT. Second, we show that the TCS model can recapitulate the experimental phenomenon that the required concentration of exogenous TGF-β for the activation of SNAIL is lower than that for the activation of ZEB1, attributing to the stronger inhibition of ZEB1 by miR-200 than the inhibition of SNAIL by miR-34 (47, 48) . In addition, the TCS modeling results show that the tristability is more apparent for ZEB1 mRNA than that for ZEB1 protein, which again highlights the microRNA-mediated regulation. Third, the TCS modeling results suggest that the inhibition of miR-34 by ZEB1 can stabilize mesenchymal phenotype. Other interactions, although not exclusively, that can also help maintain mesenchymal phenotype is ZEB1 self-activation (Figure S11) (Figure 3) , (b) the distribution of ZEB1/2 mRNA levels, as compared with ZEB1/2 protein levels, appears closer to being trimodal, and (c) although the cell lines belonging to different cancer types (29, 44, 66) have been classified into E, E/M, and M based on such ensemble measurements, recent studies have shown that cell lines can harbor phenotypic heterogeneity, therefore underlining the need to conduct single-cell studies (67) . Second, in addition to these dose-response experiments, time-course measurements of levels of ZEB1/2, SNAIL1/2, miR-200, miR-34 and FOXC2, need to be performed to elucidate temporal dynamics of EMT.
The hybrid E/M state (partial EMT) has gradually drawn attention due to its proposed crucial role in tumor progression and organ fibrosis (11, 68, 69) . The hybrid E/M state allows collective migration of CTCs as a cluster and these CTC clusters can evade immune attack (70) and often have much higher metastatic potential than the individually migrating CTCs (13) . The TCS model can be utilized to identify certain 'phenotypic stability factors' (PSFs) (71) , such as OVOL and GRHL2 (45) , which can stabilize a 'metastable' partial EMT phenotype and thus being potential targets to 'break' the clusters of CTCs -the primary 'bad agents' of metastasis (11, 13) . In future, the landscape approach (72,73) could be utilized to quantify the stability of the hybrid E/M state and transition processes during EMT and MET. These insights can move us a step closer to understanding and eventually quantitatively predicting the population heterogeneity in an isogenic population (74) .
In addition, cells undergoing EMT have been shown to acquire tumor-initiating and/or drugresistance properties (often together referred to as 'stemness' in the context of Cancer Stem Cells) and to induce cell cycle arrest (11, 54, 69, 75, 76) . By coupling the TCS model of EMT with the stemness model -LIN28/let-7/OCT4 in our previous work, we showed that 'stemness window' can slide on the 'EMT axis', or in other words, EMT-stemness correspondence can be fine-tuned by multiple players such as miR-200 that inhibits LIN28, and by PSFs such as OVOL (53) . We also showed that JAG1 -a potential intercellular PSF -can mediate drug resistance (12) . Such a dynamic positioning of the 'stemness window' can reconcile many apparently contradictory experiments about the effect of EMT/MET on stemness (77) -(a) complete EMT increases stemness (54, 56) , (b) MET increases stemness (78) and (c) partial EMT possesses maximum stemness (14, 15) . Future work to integrate the TCS model with regulatory networks for different 'hallmarks of cancer'(79) should be done to extend our understanding of EMT mechanisms and anti-metastasis strategies.
Conclusions
Our integrative modeling and experimental analyses of EMT/MET core network -miR-34/SNAIL/miR-200/ZEB1 -help distinguish mechanisms underlying EMT tristability, propose further experiments to decode the EMT dynamics more explicitly, and serve as a platform to identify certain 'underlying basic principles' pertaining to different hallmarks of cancer.
Methods

The model formulation and analyses
The detailed introduction of both the ternary switch (TCS) model and the cascading bistable switches (CBS) model can be found in the supplemental information Section 1&2.
(1) Deterministic analysis
The bifurcation diagrams of the EMT circuits are calculated by the Matcont package in Matlab.
The temporal dynamics of the EMT circuits are calculated by the ode15s solver in Matlab.
(2) Stochastic simulation
For the single-cell simulation, a Langevin equation is used to describe the dynamic behaviors of the EMT circuits with the Gaussian white noise and the Euler-Maruyama method is used to integrate the equation (80) .
For population-averaged calculation, 100 sets of parameters for the EMT circuit-miR-34/SNAIL/miR-200/ZEB1 were generated by parameter randomization (each parameter except for the hill coefficients is increased or decreased randomly up to 5% of the original value) to mimic the cell-cell variability. The random sampling follows a normal distribution. As for the hill coefficient, it follows the normal distribution within [ − 1, + 1], where is the original value.
The effective landscape (81, 82) for the stable state (E or E/M or M) is defined by E = − , where represents the probability of the stable state X to be observed.
Analysis of gene expression data from NCI-60 cell lines
The expression levels of ESRP1, ZEB1, VIM, CDH1, OVOL2 were downloaded from Cellminer (83) and categorized into E, E/M, and M sets based on CDH1/VIM ratio (29 
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